Vivendi's price target has been revised by UBS after the company's recent split. The new target is €3, down from the previous €10.

Despite this adjustment, the analyst still recommends buying the stock, as they believe it offers an attractive risk/reward ratio for investors. UBS's updated target reflects their assessment of the company's potential in the current market environment.

It is important for investors to carefully consider this information and seek guidance from professional advisors if they are unsure before making any investment decisions.